COMMUNIQUÉS West-GlobeNewswire

Eurobio Scientific : compte-rendu de l’assemblée générale ordinaire et extraordinaire annuelle
28/06/2019
Compte-rendu de l’assemblée générale ordinaire et extraordinaire annuelle d’Eurobio Scientific Les actionnaires ont adopté toutes les résolutions à titre ordinaire et à titre extraordinaire Approbation de l’apport en [...]
BBS announces the subscription price of its ongoing share issue: 28,10 SEK
28/06/2019
BBS – Bioactive Bone Substitutes Oyj (“BBS or “Company”), an innovator in orthobiologics, announces that the subscription price per share in its ongoing share issue (the “Offering”) is 28,10 SEK. The subscription price [...]
Eko Unveils Algorithm to Assist in the Detection of Aortic Stenosis, a Valvular Heart Disease Affecting Over 3 Million People in the U.S.
28/06/2019
The investigational Aortic Stenosis (AS) algorithm, tested in partnership with Northwestern Memorial Hospital, can help quickly confirm suspected AS with a sensitivity of 97.2% and a specificity of 86.4% Berkeley, June [...]
Progenics Reiterates Targeted Directors’ Indispensable Experience and Leadership Critical to the Company’s Long-Term Success
28/06/2019
Comments on ISS Report Urges Shareholders to Vote “FOR” All of the Company’s Qualified Directors on the WHITE Proxy Card NEW YORK, June 28, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) (“ [...]
Saniona’s rights issue completed
28/06/2019
PRESS RELEASE NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION [...]
Total number of shares and voting rights in Zealand Pharma at June 30, 2019
28/06/2019
Company announcement – No. 23 / 2019 Total number of shares and voting rights in Zealand Pharma at June 30, 2019 Copenhagen, June 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a [...]
New company takes over Certified Advisor role to OV
28/06/2019
Investor News Hoersholm, Denmark and Cambridge, MA, US, June 28, 2019. – Oncology Venture A/S (“OV” or the Company”) today announces that the Company will follow its main contact at its current Certified Advisor, [...]
Ascent Industries Receives Approval to Continue Operations Under Existing Licensing Following Clark County Hearing
28/06/2019
VANCOUVER, British Columbia, June 28, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. (CSE: ASNT) ("Ascent") announces the successful conclusion of the Clark County Nevada license hearing. The outcome allows the [...]
Managers' transactions
28/06/2019
Company Announcement No. 11/2019 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 Attachment No 11 [...]
BeiGene Granted Approval to Transition from the Biotech Chapter of the Hong Kong Stock Exchange to a General Listing
28/06/2019
CAMBRIDGE, Mass. and BEIJING, China, June 28, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Akari Therapeutics, Plc Announces $4.5 Million Registered Direct Offering
28/06/2019
NEW YORK and LONDON, June 28, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where [...]
Generex Announces Update on 1:1 Dividend and NASDAQ Listing
28/06/2019
MIRAMAR, Fla., June 28, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today provided guidance on the previously announced 1:1 [...]
Blissco Announces Q1 2020 Financial Results
28/06/2019
1 st quarter reporting company revenue of $742,285 21 dried flower & pre-rolled Blissco products for sale in select Canadian provinces Subsequent to quarter end, entered into definitive arrangement agreement with [...]
Sorrento Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
28/06/2019
SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical stage, antibody-centric biopharmaceutical company developing new therapies to turn malignant cancers into [...]
Q BioMed Files for Orphan Drug Designation with U.S. FDA for Autism Spectrum Disorder Subtype
28/06/2019
Currently no effective treatment exists for the 20,000 children in the U.S. and 250,000 born worldwide each year with pediatric minimally verbal autism (PMVA) NEW YORK, June 28, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. ( [...]
Managers’ transactions
28/06/2019
BioPorto A/S Managers' Transactions June 28, 2019 Company announcement no. 11 Managers’ transactions BioPorto A/S has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below [...]
Changes in number of shares and votes
28/06/2019
June 28, 2019 Announcement no. 10 Changes in number of shares and votes Completion of share capital increase The Board of Directors of BioPorto A/S (“BioPorto”) decided on June 17, 2019 to partially exercise the [...]
Medexus Pharmaceuticals Schedules Fourth Quarter and Fiscal 2019 Conference Call
28/06/2019
Conference call to be held at 4:30 PM Eastern Time on Monday, July 8, 2019 MONTREAL, June 28, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced [...]
Replimune Reports Fourth Fiscal Quarter and Year 2019 Financial Results and Provides Corporate Update
28/06/2019
RP1: Initiated Phase 2 part of Phase 1/2 clinical trial of RP1 in combination with nivolumab in the U.S. and the U.K. RP1: Initial Data from Phase 1 part of Phase 1/2 clinical trial expected to be presented in the [...]

Pages